Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers ; volume:79 ; number:6 ; day:15 ; month:4 ; year:2023 ; pages:775-787 ; date:6.2023
European journal of clinical pharmacology ; 79, Heft 6 (15.4.2023), 775-787, 6.2023

Creator: Edwina, Angela Elma
Koch, Birgit C. P.
Muller, Anouk E.
Jalali, Valentin al
Matzneller, Peter
Zeitlinger, Markus
Sassen, Sebastiaan D. T.

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00228-023-03477-5

URN: urn:nbn:de:101:1-2023091208303695287231

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:53 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Edwina, Angela Elma
Koch, Birgit C. P.
Muller, Anouk E.
Jalali, Valentin al
Matzneller, Peter
Zeitlinger, Markus
Sassen, Sebastiaan D. T.
SpringerLink (Online service)

Other Objects (12)

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers

Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I—Penicillins

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers

Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers

Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I—Penicillins

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers

Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers

Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I—Penicillins

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers

Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers

Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I—Penicillins

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers

Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers

Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I—Penicillins

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers

Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19

Pharmacokinetics of chloroquine and primaquine in healthy volunteers

Pharmacokinetics of oral and intravenous melatonin in healthy volunteers

Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients

Population Pharmacokinetics of Brigatinib in Healthy Volunteers and Patients With Cancer

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers

The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment

Pharmacokinetics and Target Attainment of Antimicrobial Drugs Throughout Pregnancy: Part I—Penicillins

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers

Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study

Related objects

Reset password